F
$ Value
$347K
Shares
4,961
Price
$70
Filed
Jul 16
Insider
Name
Hoppenot Herve
Title
Special Advisor to the CEO
CIK
0001596492
Roles
Director
Officer
Transaction Details
Transaction Date
2025-07-14
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
521,859
Footnotes
Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. | This includes an aggregate of 73,486 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
Filing Info
Hoppenot Herve's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-09-08 | BCYC | A | $0 |
| 2025-09-08 | BCYC | A | $0 |
| 2025-07-15 | INCY | F | $322K |
| 2025-07-14 | INCY | F | $347K |
| 2025-07-02 | INCY | F | $2.9M |
| 2025-06-26 | INCY | A | $0 |
| 2025-06-26 | INCY | A | $0 |
| 2025-06-26 | INCY | A | $0 |
Other Insiders at INCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HARRIGAN EDMUND | — | — | 2026-03-31 |
|
CAGNONI PABLO J
President, Global Head of R&D
|
— | $1.8M | 2026-04-17 |
| BAKER BROS. ADVISORS LP | — | — | 2026-03-31 |
| Clancy Paul J | — | — | 2026-03-31 |
|
Meury William
Chief Executive Officer
|
— | — | 2026-04-15 |
|
Stein Steven H
CMO & Head of Late-Stage Dev.
|
— | — | 2026-04-15 |
|
Trotta Matteo
EVP, GM, Dermatology US
|
— | — | 2026-03-25 |